 ATLANTA--BUSINESS WIRE--- VIRI Biotech--Virios Therapeutics, Inc. Nasdaq: VIRI, a clinical-stage biotechnology company focused on advancing novel antiviral therapies to treat debilitating chronic diseases, announced today that Greg Duncan, Chairman and Chief Executive Officer, will present a company overview at the SNN Network Summer Virtual Conference on August 19, 2021 at 9:00 a.m. ET. The presentation will focus on the role of activated viruses triggering a wide range of conditions, including fibromyalg 